PureTech’s oral drug delivery work spawns clinical-phase challenger to Sage in depressionnews2021-12-07T14:28:25+00:00December 7th, 2021|Fierce Pharma|
Sixfold bags VC funding to expand RNA delivery beyond the livernews2021-12-07T13:42:13+00:00December 7th, 2021|Fierce Pharma|
Sixfold bags VC funding to expand RNA delivery beyond the livernews2021-12-07T13:42:13+00:00December 7th, 2021|Fierce Pharma|
Visus closes in on AbbVie with midphase data on long-sightedness eye dropnews2021-12-07T13:34:05+00:00December 7th, 2021|Fierce Pharma|
Visus closes in on AbbVie with midphase data on long-sightedness eye dropnews2021-12-07T13:34:05+00:00December 7th, 2021|Fierce Pharma|
AbbVie’s Rinvoq notches Crohn’s disease win amid classwide JAK safety concernsnews2021-12-06T18:36:31+00:00December 6th, 2021|Fierce Pharma|
Merck taps Thermo Fisher to manufacture COVID pill in Canada for global rollout pushnews2021-12-06T16:11:41+00:00December 6th, 2021|Fierce Pharma|
Lawmakers to unveil findings on long-running drug pricing probe and discuss reformsnews2021-12-06T15:47:17+00:00December 6th, 2021|Fierce Pharma|
AbbVie’s Rinvoq, Pfizer’s Xeljanz and Lilly’s Olumiant slapped with new FDA warnings amid JAK safety crackdownnews2021-12-06T15:26:18+00:00December 6th, 2021|Fierce Pharma|
Merck’s Hilleman Laboratories tees up $58M investment at new Singapore vaccine hubnews2021-12-06T15:04:44+00:00December 6th, 2021|Fierce Pharma|
